Evidence map›Paper›PMID 37351469›Full record

ReviewFrontiers in bioengineering and biotechnology2023

The clinical effectiveness of staple line reinforcement with different matrix used in surgery.

Wei Jing, Yiqian Huang, Jin Feng, Hongyang Li, Xueqiao Yu, Bo Zhao, Pengfei Wei

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei JingBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Yiqian HuangBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Jin FengBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Hongyang LiBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Xueqiao YuBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Bo ZhaoBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.
Pengfei WeiBeijing Biosis Healing Biological Technology Co., Ltd., Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staplers are widely used in clinics; however, complications such as bleeding and leakage remain a challenge for surgeons. To tackle this issue, buttress materials are recommended to reinforce the staple line. This Review provides a systematic summary of the characteristics and applications of the buttress materials. First, the physical and chemical properties of synthetic polymer materials and extracellular matrix used for the buttress materials are introduced, as well as their pros and cons in clinical applications. Second, we review the clinical effects of reinforcement mesh in pneumonectomy, sleeve gastrectomy, pancreatectomy, and colorectal resection. Based on the analysis of numerous research data, we believe that buttress materials play a crucial role in increasing staple line strength and reducing the probability of complications, such as bleeding and leakage. However, considering the requirements of bioactivity, degradability, and biosafety, non-crosslinked small intestinal submucosa (SIS) matrix material is the preferred candidate. It has high research and application value, but further studies are required to confirm this. The aim of this Review is to provide comprehensive guidance on the selection of materials for staple line reinforcement.

Indexed as

bovine pericardiumexpanded polytetrafluoroethylene (ePTFE)polyglycolic acid (PGA)small intestinal submucosa (SIS)staple line reinforcement

Identifiers

PMID37351469
PMCPMC10282759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.